Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

× No keyword cloud information.

69 in total

1. Antibodies against the large subunit of the EBV-encoded ribonucleotide reductase in patients with nasopharyngeal carcinoma.

Authors: M Ginsburg
Journal: Int J Cancer Date: 1990-06-15 Impact factor: 7.396

2. Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma.

Authors: M Y Liu; W H Chou; L Nutter; M M Hsu; J Y Chen; C S Yang
Journal: J Med Virol Date: 1989-06 Impact factor: 2.327

3. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study.

Authors: F de-Vathaire; H Sancho-Garnier; H de-Thé; C Pieddeloup; G Schwaab; J H Ho; R Ellouz; C Micheau; M Cammoun; Y Cachin
Journal: Int J Cancer Date: 1988-08-15 Impact factor: 7.396

4. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors: J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal: N Engl J Med Date: 1985-12-19 Impact factor: 91.245

5. Epstein-Barr virus-induced polypeptides: a comparative study with superinfected Raji, IUdR-Treated, and N-butyrate-treated P3HR-1 cells.

Authors: M Kawanishi; K Sugawara; Y Ito
Journal: Virology Date: 1981-02 Impact factor: 3.616

6. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome.

Authors: R I Fox; G Pearson; J H Vaughan
Journal: J Immunol Date: 1986-11-15 Impact factor: 5.422

7. Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity.

Authors: T Ooka; A Calender; M de Turenne; J Daillie
Journal: J Virol Date: 1983-04 Impact factor: 5.103

8. Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus.

Authors: W C Uen; J Luka; G R Pearson
Journal: Int J Cancer Date: 1988-04-15 Impact factor: 7.396

9. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma.

Authors: J Y Chen; M Y Liu; C J Chen; M M Hsu; S M Tu; H H Lee; S L Kuo; C S Yang
Journal: J Med Virol Date: 1985-09 Impact factor: 2.327

10. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors: M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal: J Infect Dis Date: 1985-11 Impact factor: 5.226

7 in total

Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

1. Antibodies against the large subunit of the EBV-encoded ribonucleotide reductase in patients with nasopharyngeal carcinoma.

2. Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma.

3. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study.

4. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

5. Epstein-Barr virus-induced polypeptides: a comparative study with superinfected Raji, IUdR-Treated, and N-butyrate-treated P3HR-1 cells.

6. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome.

7. Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity.

8. Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus.

9. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma.

10. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

1. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.

2. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.

Review 3. Epstein-Barr virus and systemic lupus erythematosus.

4. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.

5. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

6. Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients.

7. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.